Rubius Therapeutics Inc (RUBY)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-02-27 | 2023-02-24 | S Sale |
CEO and President Officer |
10,385
-100.0%
0.13USD 1,323 |
10,385 -100.0% | 0.13 | USD 1,323 | |
| 2023-02-01 | 2023-02-01 | S Sale | Non-Executive Director |
8,448
-11.3%
0.25USD 2,112 |
8,448 -11.3% | 0.25 | USD 2,112 | |
| 2023-02-01 | 2023-02-01 | S Sale |
CEO and President Officer |
3,878
-27.2%
0.25USD 970 |
3,878 -27.2% | 0.25 | USD 970 | |
| 2023-01-31 | 2023-01-31 | S Sale |
Chief Scientific Officer Officer |
2,593
-12.4%
0.24USD 622 |
2,593 -12.4% | 0.24 | USD 622 | |
| 2023-01-31 | 2023-01-31 | S Sale | Non-Executive Director |
7,240
-8.9%
0.24USD 1,745 |
7,240 -8.9% | 0.24 | USD 1,745 | |
| 2022-08-12 | 2022-08-10 | S Sale |
Chief Operating Officer Officer |
5,737
-45.9%
0.80USD 4,590 |
5,737 -45.9% | 0.80 | USD 4,590 | |
| 2022-04-22 | 2022-04-21 | B Purchase | Non-Executive Director |
30,000
+0.6%
1.44USD 43,329 |
30,000 +0.6% | 1.44 | USD 43,329 | |
| 2022-02-01 | 2022-02-01 | S Sale |
Chief Scientific Officer Officer |
2,517
-33.8%
6.57USD 16,544 |
2,517 -33.8% | 6.57 | USD 16,544 | |
| 2022-02-01 | 2022-02-01 | S Sale |
CEO and President Executive Director |
6,730
-15.9%
6.57USD 44,236 |
6,730 -15.9% | 6.57 | USD 44,236 | |
| 2022-02-01 | 2022-02-01 | S Sale |
CLO & Corp. Secretary Officer |
2,732
-33.8%
6.57USD 17,957 |
2,732 -33.8% | 6.57 | USD 17,957 | |
| 2021-03-23 | 2021-03-19 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
70,000
+2.7%
29.00USD 2,030,000 |
70,000 +2.7% | 29.00 | USD 2,030,000 | |
| 2021-03-23 | 2021-03-19 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
70,000
+1.2%
29.00USD 2,030,000 |
70,000 +1.2% | 29.00 | USD 2,030,000 | |
| 2021-03-23 | 2021-03-19 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
70,000
+0.5%
29.00USD 2,030,000 |
70,000 +0.5% | 29.00 | USD 2,030,000 | |
| 2021-03-15 | 2021-03-15 | PS Planned sale |
CLO & Corp. Secretary Officer |
25,000
-100.0%
20.24USD 505,965 |
25,000 -100.0% | 20.24 | USD 505,965 | |
| 2021-02-16 | 2021-02-11 | PS Planned sale | Non-Executive Director |
26,704
-0.6%
14.93USD 398,560 |
26,704 -0.6% | 14.93 | USD 398,560 | |
| 2021-02-10 | 2021-02-10 | PS Planned sale | Non-Executive Director |
7,404
-0.2%
14.79USD 109,525 |
7,404 -0.2% | 14.79 | USD 109,525 | |
| 2021-02-10 | 2021-02-09 | PS Planned sale | Non-Executive Director |
2,100
-0.0%
14.83USD 31,146 |
2,100 -0.0% | 14.83 | USD 31,146 | |
| 2021-02-10 | 2021-02-08 | PS Planned sale | Non-Executive Director |
89,233
-1.9%
14.88USD 1,328,117 |
89,233 -1.9% | 14.88 | USD 1,328,117 | |
| 2020-04-24 | 2020-04-22 | B Purchase |
Chief Medical Officer Officer |
19,000
+inf%
5.52USD 104,814 |
19,000 +inf% | 5.52 | USD 104,814 | |
| 2020-04-15 | 2020-04-14 | B Purchase |
CEO and President Executive Director |
21,000
+inf%
4.70USD 98,694 |
21,000 +inf% | 4.70 | USD 98,694 | |
| 2020-03-19 | 2020-03-17 | B Purchase | Non-Executive Director |
5,000
+0.1%
3.76USD 18,800 |
5,000 +0.1% | 3.76 | USD 18,800 | |
| 2020-03-17 | 2020-03-13 | B Purchase | Non-Executive Director |
5,000
+0.1%
4.00USD 20,000 |
5,000 +0.1% | 4.00 | USD 20,000 | |
| 2020-03-17 | 2020-03-13 | B Purchase | Non-Executive Director |
5,000
+0.1%
3.82USD 19,100 |
5,000 +0.1% | 3.82 | USD 19,100 | |
| 2019-12-18 | 2019-12-16 | PS Planned sale |
CARPENTER CHRISTOPHER L. Chief Medical Officer Officer |
48,000
-57.9%
13.48USD 646,901 |
48,000 -57.9% | 13.48 | USD 646,901 | |
| 2019-10-17 | 2019-10-14 | PS Planned sale |
7,500
-100.0%
8.52USD 63,875 |
7,500 -100.0% | 8.52 | USD 63,875 | ||
| 2019-09-18 | 2019-09-17 | PS Planned sale |
Chief Medical Officer |
11,877
-25.4%
10.05USD 119,309 |
11,877 -25.4% | 10.05 | USD 119,309 | |
| 2019-09-18 | 2019-09-16 | PS Planned sale |
Chief Medical Officer |
36,123
-50.9%
10.13USD 365,897 |
36,123 -50.9% | 10.13 | USD 365,897 | |
| 2019-07-17 | 2019-07-15 | PS Planned sale |
7,500
-100.0%
14.94USD 112,049 |
7,500 -100.0% | 14.94 | USD 112,049 | ||
| 2019-06-24 | 2019-06-20 | PS Planned sale |
Chief Medical Officer |
243
-0.7%
13.93USD 3,386 |
243 -0.7% | 13.93 | USD 3,386 | |
| 2019-06-19 | 2019-06-19 | PS Planned sale |
Chief Medical Officer |
18,399
-34.6%
13.80USD 253,868 |
18,399 -34.6% | 13.80 | USD 253,868 | |
| 2019-06-19 | 2019-06-18 | PS Planned sale |
Chief Medical Officer |
10,858
-23.8%
14.27USD 154,958 |
10,858 -23.8% | 14.27 | USD 154,958 | |
| 2019-06-19 | 2019-06-17 | PS Planned sale |
Chief Medical Officer |
18,500
-34.7%
14.10USD 260,869 |
18,500 -34.7% | 14.10 | USD 260,869 | |
| 2019-04-17 | 2019-04-15 | PS Planned sale |
7,500
-100.0%
17.57USD 131,799 |
7,500 -100.0% | 17.57 | USD 131,799 | ||
| 2019-04-10 | 2019-04-08 | PS Planned sale |
President |
2,100
-0.1%
20.00USD 42,000 |
2,100 -0.1% | 20.00 | USD 42,000 | |
| 2019-04-05 | 2019-04-05 | PS Planned sale |
President |
12,096
-0.7%
20.00USD 241,920 |
12,096 -0.7% | 20.00 | USD 241,920 | |
| 2019-04-05 | 2019-04-03 | PS Planned sale |
President |
500
-0.0%
20.00USD 10,000 |
500 -0.0% | 20.00 | USD 10,000 | |
| 2019-03-19 | 2019-03-15 | PS Planned sale |
Chief Medical Officer |
48,000
-57.9%
15.84USD 760,114 |
48,000 -57.9% | 15.84 | USD 760,114 | |
| 2019-01-18 | 2019-01-14 | PS Planned sale | Non-Executive Director |
7,500
-100.0%
14.59USD 109,444 |
7,500 -100.0% | 14.59 | USD 109,444 | |
| 2018-07-23 | 2018-07-20 | B Purchase |
Pomerantz Roger Non-Executive Director |
100
+inf%
23.00USD 2,300 |
100 +inf% | 23.00 | USD 2,300 | |
| 2018-07-23 | 2018-07-20 | B Purchase |
Sohn Catherine A. Non-Executive Director |
2,500
+inf%
23.00USD 57,500 |
2,500 +inf% | 23.00 | USD 57,500 | |
| 2018-07-23 | 2018-07-20 | B Purchase |
Symonds Jonathan Non-Executive Director |
25,000
+inf%
23.00USD 575,000 |
25,000 +inf% | 23.00 | USD 575,000 | |
| 2018-07-23 | 2018-07-20 | B Purchase |
Cuss Francis M Non-Executive Director |
10,000
+inf%
23.00USD 230,000 |
10,000 +inf% | 23.00 | USD 230,000 |